Capital Develop Layoffs San Diego 
TechCrunch LA
APRIL 6, 2020
I will repeat my appeal from last week: Maybe you’re a startup founder, a safety driver at an autonomous vehicle developer, a venture capitalist, engineer or gig economy worker. metro area, San Diego and Santa Monica. A novel rewards program. These times have sparked a host of new ideas. Here’s one.
socalTECH
DECEMBER 11, 2009
San Diego-based Verari Systems , a developer of blade server technology, has shut down, according to publication InsideHPC. According to InsideHPC, Verari Systems shut down due to lack of access to capital. Tags: verari systems blade server shutdown employment jobs layoff. READ MORE>>. READ MORE>>.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
DECEMBER 19, 2016
San Diego-based residential solar power installer OneRoof Energy said late Friday that it has "significantlyr educed" its work force, and has begun winding down its operations, after it said it was unable to secure financing necessary to continue sales, marketing, and development.
socalTECH
JANUARY 16, 2009
San Diego-based Cymer, a developer of light sources used for semiconductor manufacturing, said late Thursday that the firm has laid off 100 people, or 10 percent of its personnel. Tags: cymer jobs employment economy layoff semiconductor. Cymer announced the move in conjunction with reduced earnings estimates for Q4 2008.
socalTECH
SEPTEMBER 18, 2008
San Diego-based wireless broadband technology firm NextWave Wireless said today that it has scored a new, $100M debt financing for the firm's business, and made cuts in its staff, along with hiring an investment banker. The debt comes from Avenue Capital Management II, L.P. READ MORE>>
Xconomy
JULY 15, 2016
Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. based MRC Technology sold a portion of its royalty stake in Merck’s cancer immunotherapy drug pembrolizumab (Keytruda) to DRI Capital for $150 million. —With $1.25
Xconomy
JANUARY 25, 2019
After guiding the CRISPR-Cas9 genome-editing startup from scientific breakthrough toward the development of a potential cutting-edge medicine, slogging victoriously through a legendary patent fight , and reaching the cusp of an historic clinical trial , the well-traveled Bosley is cutting out, the company said Tuesday.
Expert insights. Personalized for you.
136 
Let's personalize your content